Long Focus Capital Management, LLC Aura Biosciences, Inc. Transaction History
Long Focus Capital Management, LLC
- $2.94 Billion
- Q4 2024
A detailed history of Long Focus Capital Management, LLC transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Long Focus Capital Management, LLC holds 2,537,774 shares of AURA stock, worth $20.1 Million. This represents 0.71% of its overall portfolio holdings.
Number of Shares
2,537,774
Previous 1,133,546
123.88%
Holding current value
$20.1 Million
Previous $10.1 Million
106.56%
% of portfolio
0.71%
Previous 0.37%
Shares
9 transactions
Others Institutions Holding AURA
# of Institutions
95Shares Held
40MCall Options Held
31.6KPut Options Held
29K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$55 Million2.75% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$38.8 Million0.07% of portfolio
-
Eventide Asset Management, LLC Boston, MA4.08MShares$32.4 Million0.64% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$24.1 Million5.49% of portfolio
-
Black Rock Inc. New York, NY3.01MShares$23.9 Million0.0% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $232M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...